Stockscreener 앱 받기
0.1298
5.32%
-0.0073
전일 마감가:
$0.1371
열려 있는:
$0.1324
하루 거래량:
2.92M
Relative Volume:
0.27
시가총액:
$16.44M
수익:
$23.34M
순이익/손실:
$-101.27M
주가수익비율:
-0.1005
EPS:
-1.2919
순현금흐름:
$-11.74M
1주 성능:
-9.86%
1개월 성능:
+11.51%
6개월 성능:
-88.71%
1년 성능:
-96.96%
1일 변동 폭
$0.1243
$0.1365
1주일 범위
$0.1243
$0.144
52주 변동 폭
$0.0954
$7.04
Wellgistics Health Inc Stock (WGRX) Company Profile
명칭
Wellgistics Health Inc
전화
1-843-302-1785
주소
3000 BAYPORT DRIVE SUITE 950, TAMPA
Compare WGRX vs HITI, PETS, POM, SCNX
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WGRX
Wellgistics Health Inc
|
0.1298 | 17.19M | 23.34M | -101.27M | -11.74M | -1.2919 |
HITI
High Tide Inc
|
2.47 | 210.95M | 452.61M | -35.30M | 13.25M | -0.3863 |
PETS
Petmed Express Inc
|
2.29 | 47.72M | 182.67M | -64.87M | -22.92M | -3.1193 |
POM
Pomdoctor Ltd Adr
|
0.3928 | 47.30M | 0 | 0 | 0 | 0.00 |
SCNX
Scienture Holdings Inc
|
0.4102 | 16.98M | 653.40K | -20.19M | -11.11M | -1.8091 |
Wellgistics Health Inc 주식(WGRX)의 최신 뉴스
Governance, ownership and clawback updates at Wellgistics Health (NASDAQ: WGRX) - Stock Titan
Wellgistics (NASDAQ: WGRX) seeks name change, preferred stock and 56.5M share increase - Stock Titan
Wellgistics Health files to sell 3.57M shares of common stock for holders - MSN
[Form 4] Wellgistics Health, Inc. Insider Trading Activity - Stock Titan
Director at Wellgistics (WGRX) awarded 5M shares and 5M low‑price warrants - Stock Titan
Nasdaq flags Wellgistics (NASDAQ: WGRX) as equity falls, company signs $2M Kare JV - Stock Titan
WGRX Stock Price, Quote & Chart | WELLGISTICS HEALTH INC (NASDAQ:WGRX) - ChartMill
Wellgistics Health (WGRX) Stock: Good Opportunity? (-5.56%) 2026-04-20Stock News - Cổng thông tin điện tử Tỉnh Sơn La
Wellgistics Health and Kare PharmTech Form AI-Driven Joint Venture to Expand Pharmaceutical Access to 200,000+ Patients - Minichart
Wellgistics Forms AI-Driven Pharmacy Access Joint Venture - TipRanks
Wellgistics Health (NASDAQ: WGRX) forms KareRx JV with $2M stock deal - Stock Titan
Penny stock Wellgistics Health ends Silverback deal, cuts dilution risk - MSN
WGRX Technical Analysis | Trend, Signals & Chart Patterns | WELLGISTICS HEALTH INC (NASDAQ:WGRX) - ChartMill
Wellgistics Health Files $200 Million Mixed Shelf - Moomoo
Wellgistics Health Inc may offer up to $200 million in securitiesSEC filing - marketscreener.com
Wellgistics Health IncMay Offer Up To $200 Million In SecuritiesSEC Filing - TradingView
Wellgistics Health (NASDAQ: WGRX) registers $200M shelf to offer equity, debt, warrants - Stock Titan
Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives - National Today
Rosen Law Firm Encourages Wellgistics Health Inc. Investors to Inquire About Securities Class Action Investigation – WGRX - The Joplin Globe
Wellgistics forms joint venture with KareRx Hub for pharma distribution By Investing.com - Investing.com Australia
Wellgistics Health (WGRX) Forms Strategic Joint Venture with Kar - GuruFocus
Wellgistics forms joint venture with KareRx Hub for pharma distribution - Investing.com
Rosen Law Firm Investigating Potential Securities Claims Against Wellgistics Health - National Today
Exit Recap: Is Wellgistics Health Inc stock good for income investors2026 Valuation Update & Consistent Growth Stock Picks - baoquankhu1.vn
Why Clearsign Technologies Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket - Sahm
Wellgistics Health Inc. (WGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Wellgistics Health Ends Settlement, Shifts Financing Strategy - The Globe and Mail
Wellgistics Health (WGRX) director Herman Gary L files initial Form 3 - Stock Titan
Penny Stock Wellgistics Health Ends Silverback Deal, Cuts Dilution Risk - Benzinga
Bond Watch: Is Wellgistics Health Inc undervalued by DCF analysisWall Street Watch & Fast Momentum Entry Tips - baoquankhu1.vn
Aug Ideas: What is Wellgistics Health Incs P E ratio telling usPortfolio Update Summary & Daily Profit Focused Stock Screening - baoquankhu1.vn
Is Wellgistics Health (WGRX) Stock Expanding | Price at $0.13, Up 22.64%Community Chart Signals - UBND thành phố Hải Phòng
Wellgistics Health, Inc. (WGRX) Terminates Settlement Agreement – SEC Form 8-K Filing April 3, 2026 - Minichart
Wellgistics Health (WGRX) director Eric Michael Sherb files initial Form 3 - Stock Titan
Wellgistics Health ends share settlement agreement with Silverback Capital By Investing.com - Investing.com South Africa
Wellgistics Health ends share settlement agreement with Silverback Capital - Investing.com
Wellgistics Health Terminates Section 3(a)(10) Settlement With Silverback, Halting Further Share Issuance - TradingView — Track All Markets
Wellgistics (NASDAQ: WGRX) halts 3(a)(10) share settlement plan - Stock Titan
Wellgistics Health Raises Capital via Private Note Financing - The Globe and Mail
Wellgistics Health, Inc. Enters Note Purchase Agreement: SEC Filing Details, Nasdaq Listing, and Company Information - Minichart
Wellgistics Health Launches Up to $1.25 Million Note Offering With 20% OID - TradingView — Track All Markets
Wellgistics Health (WGRX) raises $1.25M via 0% notes with covenants - Stock Titan
Wellgistics Health (WGRX) approves board-authorized 1:25–1:200 reverse split - Stock Titan
Wellgistics Health, Inc. (WGRX) Explores $105M Acquisition of Neuritek to Expand Healthcare Platform - Insider Monkey
Wellgistics Health (WGRX) director Marlene Velez files Form 3 - Stock Titan
12 Penny Stocks with Insider Buying in 2026 - Insider Monkey
Exclusive:Top Public Companies Holding XRP - Bitget
Wellgistics Health, Inc. announced that it expects to receive $1.25 million in funding - marketscreener.com
Sentiment Recap: How does Wellgistics Health Inc score in quality rankings2026 Trading Volume Trends & Technical Entry and Exit Tips - baoquankhu1.vn
Pullback Watch: Can Wellgistics Health Inc continue delivering strong returns2026 Bull vs Bear & Daily Growth Stock Tips - baoquankhu1.vn
[PRER14C] Wellgistics Health, Inc. Preliminary Revised Information Statement - Stock Titan
Wellgistics Health Inc (WGRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.87%
3.42%
자본화:
|
볼륨(24시간):